Literature DB >> 23370657

Clinical and pathologic characteristics of serous carcinoma confined to the endometrium: a multi-institutional study.

Assaad Semaan1, Ismail Mert, Adnan R Munkarah, Sudeshna Bandyopadhyay, Haider S Mahdi, Ira S Winer, Marisa R Nucci, Yaser Hussein, Faisal Quershi, Kinda Hayek, Farah Tabassum, Baraa Alosh, Daniel S Schultz, Michele L Cote, Koen K Van de Vijver, Robert T Morris, Esther Oliva, Rouba Ali-Fehmi.   

Abstract

The objective of this study was to analyze the clinical and pathologic factors in patients with uterine serous carcinoma confined to the endometrium. A total of 236 uterine serous carcinoma patients from the pathology databases of 4 large academic institutions were included in the study. Clinical and pathologic variables were analyzed, including patient demographics, tumor size (≤2 vs. >2 cm), myometrial invasion, lymphovascular invasion, lymph node status, tumor location (endometrium vs. polyp), cervical involvement, lower uterine segment involvement, FIGO stage, pelvic washings, recurrence, overall survival, and progression-free survival. Of 236 patients, 55 (23%) had tumors limited to the endometrium. Forty-four patients (80%) had Stage IA tumors. The tumor was confined to a polyp in 17 (30.9%) patients. Twenty patients (36.4%) had tumor sizes >2 cm and 12 (21.8%) exhibited lymphovascular invasion. Only 3 patients (5.4 %) had cervical stromal involvement. Thirty-three (66%) patients underwent pelvic and para-aortic lymphadenectomy with 2 positive para-aortic lymph nodes identified. Seven (12.7%) patients had positive washings, whereas 8 patients (14.5 %) had disease recurrence. At a median follow-up of 46 months, there was no difference in overall survival (P = 0.216) or progression-free survival (P=0.063) between patients with tumors confined to a polyp, patients with tumors confined to the endometrium, and patients with tumors present in both polyp and the endometrium. Uterine serous carcinoma with only endometrial involvement, even when confined to a polyp, can be associated with poor prognosis, further stressing the importance of complete surgical staging and adjuvant treatment in this setting.

Entities:  

Mesh:

Year:  2013        PMID: 23370657     DOI: 10.1097/PGP.0b013e318273fc55

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  7 in total

Review 1.  Practical issues in the diagnosis of serous carcinoma of the endometrium.

Authors:  Sonia Gatius; Xavier Matias-Guiu
Journal:  Mod Pathol       Date:  2016-01       Impact factor: 7.842

Review 2.  Müllerian intra-abdominal carcinomatosis in hereditary breast ovarian cancer syndrome: implications for risk-reducing surgery.

Authors:  Murray Joseph Casey; Agnes B Colanta
Journal:  Fam Cancer       Date:  2016-07       Impact factor: 2.375

3.  Detection of ERBB2 amplification in uterine serous carcinoma by next-generation sequencing: an approach highly concordant with standard assays.

Authors:  Carrie L Robinson; Beth T Harrison; Azra H Ligon; Fei Dong; Valeria Maffeis; Ursula Matulonis; Marisa R Nucci; David L Kolin
Journal:  Mod Pathol       Date:  2020-10-19       Impact factor: 7.842

4.  The role of omentectomy in the surgical treatment of uterine serous carcinoma.

Authors:  Ming Chen; Peng Guo; Jifan Tan; Duo Liu; Shuzhong Yao
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2019-07-10

5.  A 4-gene signature predicts prognosis of uterine serous carcinoma.

Authors:  Hui Chen; Lingjun Li; Ping Qin; Hanzhen Xiong; Ruichao Chen; Minfen Zhang; Qingping Jiang
Journal:  BMC Cancer       Date:  2021-02-12       Impact factor: 4.430

6.  Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/ Gynecologic Oncology Group 210 Trial.

Authors:  Ashley S Felix; Louise A Brinton; D Scott McMeekin; William T Creasman; David Mutch; David E Cohn; Joan L Walker; Richard G Moore; Levi S Downs; Robert A Soslow; Richard Zaino; Mark E Sherman
Journal:  J Natl Cancer Inst       Date:  2015-06-18       Impact factor: 13.506

7.  Distant recurrence in a patient with polyp-confined stage IA serous endometrial carcinoma treated with adjuvant chemotherapy: A case report and review of literature.

Authors:  Annalyn Welp; Sarah Temkin; Stephanie Sullivan
Journal:  Gynecol Oncol Rep       Date:  2019-11-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.